The in-vitro activity of povidone-iodine cream against Staphylococcus aureus and its bioavailability in nasal secretions

R L R Hill, M W Casewell

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)

Abstract

Due to the emergence of mupirocin-resistance in some epidemic strains of methicillin-resistant Staphylococcus aureus (EMRSA) and the appearance of EMRSA with intermediate resistance to vancomycin, we evaluated the in-vitro activity of 5% povidone-iodine ('Betadine') cream as a possible alternative to mupirocin for the elimination of nasal carriage of S. aureus. As judged by enrichment culture, povidone-iodine was bactericidal against three mupirocin-sensitive strains of S. aureus from nasal carriers, and against mupirocin-resistant and -sensitive strains of EMRSA types 3, 15 and 16, after incubation with povidone-iodine for 1.0 min at 32 degrees C. Mupirocin nasal ointment did not prevent growth after 180 min incubation. In a quantitative suspension test, 1:100 dilution of povidone-iodine cream completely eliminated an inoculum of 10(8) cfu/mL of all nine test organisms after incubation at 32 degrees C for 1.0 mill, and 1 : 1000 dilution reduced cfu, by a factor of 10(5). After direct inoculation of the povidone-iodine cream to give 10(5) cfu/g, none of the test strains were recoverable after 30 s, giving a killing rate of approximately 10(4)cfu/s; for mupirocin nasal ointment, the maximum reduction of mupirocin-sensitive strains was ten fold after 3h. Povidone-iodine activity was not detectable in sensitivity-testing agar, although 0.025% of povidone-iodine was detectable in a 15% nutrient strength tryptone soya agar. Using this minimal medium, the addition of nasal secretions (from any of 11 samples) reduced the activity of povidone-iodins by 80-90%, but mupirocin activity was unaffected. One millilitre of nasal secretions inactivated the equivalent of approximately 22.5 mg of povidone-iodine. These results suggest that povidone-iodine cream may have a role in the prevention of colonization and infection caused by MRSA, including mupirocin-resistant strains. (C) 2000 The Hospital Infection Society.
Original languageEnglish
Pages (from-to)198 - 205
Number of pages8
JournalJournal of Hospital Infection
Volume45
Issue number3
DOIs
Publication statusPublished - Jul 2000

Fingerprint

Dive into the research topics of 'The in-vitro activity of povidone-iodine cream against Staphylococcus aureus and its bioavailability in nasal secretions'. Together they form a unique fingerprint.

Cite this